Dexmedetomidine trials for Anxiety

All Dexmedetomidine trials · All Anxiety trials

Phase breakdown

Recruiting trials studying Dexmedetomidine for Anxiety

• Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia
  NCT06853431 · Phase: Phase 4 · Ages: 12 Months to 72 Months · Sex: All (male and female) · 2 locations
• Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia
  NCT05681572 · Phase: Phase 3 · Ages: 7 Years to 18 Years · Sex: All (male and female) · 1 location
• Intranasal Dexmedetomidine for Acute Anxiety State in Adults
  NCT07550881 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Intranasal Dexmedetomidine vs Oral Midazolam for Premedication in Pediatric Surgery
  NCT07565116 · Phase: Not applicable (e.g. observational or device study) · Ages: 2 Years to 10 Years · Sex: All (male and female) · 1 location
• Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section
  NCT07343843 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location

Common questions

How many trials study Dexmedetomidine for Anxiety?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.